Laddar...
Response to nivolumab in metastatic collecting duct carcinoma expressing PD-L1: A case report
The authors present a case report of collecting duct carcinoma (CDC) that responded to nivolumab, a programmed death 1 (PD-1) immune-checkpoint-inhibitor antibody, following the failure of systemic treatment with chemotherapy and targeted therapy. The patient underwent right radical nephrectomy and...
Sparad:
| I publikationen: | Mol Clin Oncol |
|---|---|
| Huvudupphovsmän: | , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
D.A. Spandidos
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5740828/ https://ncbi.nlm.nih.gov/pubmed/29285361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1449 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|